skip to main content
$40 Million Series C Financing of Protagonist Therapeutics, Inc.

Represented Canaan Partners as a lead investor in successfully closing a $40 million Series C financing for Protagonist Therapeutics, Inc., a biotechnology company. The investment will fund continued advancement of the company’s oral peptide drugs for inflammatory bowel disease and other gastrointestinal diseases and disorders into clinical development.

SIGNIFICANT RULING CLARIFIES SCOPE OF ENVIRONMENTAL REGULATION

Secured a victory in Tilcon Connecticut, Inc. v. Commissioner of Environmental Protection on behalf of our client, a leading supplier of quality earth materials. The Connecticut Supreme Court’s ruling prohibits the Department of Energy & Environmental Protection from using applications filed under the state’s Water Diversion Policy Act as a basis to inquire into activities that are not related to the activity for which a permit is required. This important clarification has the potential to benefit all businesses subject to Connecticut environmental regulation.

Recapitalization for Construction Supply Industry Leader

We represented A.H. Harris & Sons, Incorporated in a significant recapitalization transaction, including restructuring the company’s equity and debt, with leading private equity firm, Frontenac.  The transaction involved a cross-disciplinary team of attorneys practicing various aspects of business, environmental, tax and employee benefits law.